ZED-1227

Highest phase reached
Drug type
Small molecule

Listing at source
Listed
Highest phase reached

Drug type
Small molecule
Drug name
Molecular weight
Structure (SMILES)
CCC(CC)CNC(=O)Cn1cccc(NC(=O)[C@H](CC/C=C/C(=O)OC)NC(=O)c2cncn2C)c1=O

  • tak 227
  • Tak-227
  • TAK-227
  • vilagletistat
  • Vilagletistat
  • vilagletistat [INN]
  • vilagletistat inn
  • zed 1227
  • Zed-1227
  • zed1227
  • ZED1227

CAS registry numbers
  • 1542132-88-6
ChEMBL ID
CHEMBL4081588
InChIKey
VHGWUSABWIEXKQ-BEBFYNPSSA-N
PubChem compound IDs
  • 72950407
FDA ingredient codes (UNII)
  • T4SR539YKF

First in class
No
Orphan designation
No

Pharmacology name
vilagletistat
Type
Synthetic organic

  • Action type
    Inhibitor
    Target
    transglutaminase 2
    Gene symbol
    transglutaminase 2
  • Action
    Inhibition
    Action type
    Inhibitor
    Target
    transglutaminase 2
    Gene symbol
    TGM2
    Protein identifier
    P21980
    Median affinity
    7.28
    Affinity units
    pIC50

  • Condition identifier
    EFO_0001060
    Highest recorded phase
    2
  • Condition identifier
    EFO_0003095
    Highest recorded phase
    2
  • Condition identifier
    EFO_0006890
    Highest recorded phase
    2
  • Condition identifier
    MONDO_0005130
    Highest recorded phase
    2
  • Condition identifier
    MONDO_0013209
    Highest recorded phase
    2

Hydrogen bond acceptors
9
Hydrogen bond donors
3
Polar surface area
153.42
Calculated partition coefficient (ALogP)
1.38
Calculated partition coefficient (XLogP)
1.6
Prodrug
No
Chirality
Single enantiomer
Inorganic
No
Rule-of-five violations
1
Rotatable bonds
14
Heavy atoms
38
Molecular formula
C26H36N6O6
Monoisotopic mass
528.26963289
Natural product
No

Recorded assays
7
Active assays
2

Active assay types

  • Confirmatory

Related records

Trials (3)

In development for (2)